Skip to main content

Advanced Drug Delivery Nanosystems: Perspectives and Regulatory Issues

  • Conference paper
  • First Online:
GeNeDis 2014

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 822))

Abstract

This chapter deals with the classification of Drug Delivery nano Systems (DDnSs) with a Modulatory Controlled Release profile (MCR) denoted as Modulatory Controlled Release nano Systems (MCRnSs). Conventional (c) and advanced (a) DDnSs are denoted by the acronyms cDDnSs and aDDnSs, and can be composed of a single or more than one biomaterials, respectively. The classification was based on their characteristics such as surface functionality (f), the nature of biomaterials used, and the kind of interactions between biomaterials. The aDDnSs can be classified as Hybridic (Hy-) or Chimeric (Chi-) based on the nature—same or different, respectively—of biomaterials and inorganic materials used. The nature of the elements used for producing advanced biomaterials is of great importance and medicinal chemistry contributes effectively to the production of aDDnSs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gaspar R, Aksu B, Cuine A, Danhof M, Takac MJ, Linden HH, Link A, Muchitsch EM, Rowland M, Noe CR, Smith DA, Tucker GT, Crommelin DJ, Peck CC, Rocci ML Jr, Basançon L, Shah VP (2012) Impact of the pharmaceutical sciences on health care: a reflection over the past 50 years. J Pharm Sci 101:4075

    Article  Google Scholar 

  2. Gardikis K, Hatziantoniou S, Bucos M, Fessas D, Signorelli M, Felekis T, Zervou M, Screttas C, Steele B, Ionov M, Scretta M, Klajnert B, Bryszewska M, Demetzos C (2010) New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy. J Pharm Sci 99:3561

    Article  CAS  PubMed  Google Scholar 

  3. Pippa N, Pispas S, Demetzos C (2012) The fractal hologram and elucidation of the structure of liposomal carriers in aqueous and biological media. Int J Pharm 430:65

    Article  CAS  PubMed  Google Scholar 

  4. Pippa N, Pispas S, Demetzos C (2012) The delineation of the morphology of charged liposomal vectors via a fractal analysis in aqueous and biological media: physicochemical and self-assembly studies. Int J Pharm 437:264

    Article  CAS  PubMed  Google Scholar 

  5. Pippa N, Kaditi E, Pispas S, Demetzos C (2013) PEO-b-PCL:DPPC chimeric nanocarriers: self-assembly aspects in aqueous and biological media and drug incorporation. Soft Matter 9:4073

    Article  CAS  Google Scholar 

  6. Pippa N, Merkouraki M, Pispas S, Demetzos C (2013) DPPC:MPOx chimeric advanced Drug Delivery nano Systems (chi-aDDnSs): physicochemical and structural characterization, stability and drug release studies. Int J Pharm 450:1

    Article  CAS  PubMed  Google Scholar 

  7. Demetzos C, Pippa N (2014) Advanced drug delivery nano systems (aDDnSs): a mini-review. Drug Deliv 21(4):250–257

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Costas Demetzos .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this paper

Cite this paper

Demetzos, C. (2015). Advanced Drug Delivery Nanosystems: Perspectives and Regulatory Issues. In: Vlamos, P., Alexiou, A. (eds) GeNeDis 2014. Advances in Experimental Medicine and Biology, vol 822. Springer, Cham. https://doi.org/10.1007/978-3-319-08927-0_22

Download citation

Publish with us

Policies and ethics